Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Li X, Liu N, Zhang H, Knudson SE, Slayden RA, Tonge PJ.

Bioorg Med Chem Lett. 2010 Nov 1;20(21):6306-9. doi: 10.1016/j.bmcl.2010.08.076.

2.

Highly active potential antituberculotics: 3-(4-alkylphenyl)-4-thioxo-2H-1,3-benzoxazine-2(3H)-ones and 3-(4-alkylphenyl)-2H-1,3-benzoxazine-2,4(3H)-dihiones substituted in ring-B by halogen.

Waisser K, Matyk J, Kunes J, Dolezal R, Kaustová J, Dahse HM.

Arch Pharm (Weinheim). 2008 Dec;341(12):800-3. doi: 10.1002/ardp.200800004.

PMID:
19006090
3.

Highly active antimycobacterial derivatives of benzoxazine.

Petrlíková E, Waisser K, Divišová H, Husáková P, Vrabcová P, Kuneš J, Kolář K, Stolaříková J.

Bioorg Med Chem. 2010 Dec 1;18(23):8178-87. doi: 10.1016/j.bmc.2010.10.017.

PMID:
21044844
4.

CoA Adducts of 4-Oxo-4-Phenylbut-2-enoates: Inhibitors of MenB from the M. tuberculosis Menaquinone Biosynthesis Pathway.

Li X, Liu N, Zhang H, Knudson SE, Li HJ, Lai CT, Simmerling C, Slayden RA, Tonge PJ.

ACS Med Chem Lett. 2011 Nov 10;2(11):818-823.

5.

Substituted 4-methylquinolines as a new class of anti-tuberculosis agents.

Jain R, Vaitilingam B, Nayyar A, Palde PB.

Bioorg Med Chem Lett. 2003 Mar 24;13(6):1051-4.

PMID:
12643909
6.

Synthesis and screening of (E)-1-(β-D-galactopyranosyl)-4-(aryl)but-3-ene-2-one against Mycobacterium tuberculosis.

Mugunthan G, Ramakrishna K, Sriram D, Yogeeswari P, Ravindranathan Kartha KP.

Bioorg Med Chem Lett. 2011 Jul 1;21(13):3947-50. doi: 10.1016/j.bmcl.2011.05.037.

PMID:
21641797
7.
8.

Synthesis and antitubercular activity of novel amino acid derivatives.

Da Costa CF, Pinheiro AC, De Almeida MV, Lourenço MC, De Souza MV.

Chem Biol Drug Des. 2012 Feb;79(2):216-22. doi: 10.1111/j.1747-0285.2011.01269.x.

PMID:
22078007
9.
10.

Novel 1,4-substituted-1,2,3-triazoles as antitubercular agents.

Altimari JM, Hockey SC, Boshoff HI, Sajid A, Henderson LC.

ChemMedChem. 2015 May;10(5):787-91. doi: 10.1002/cmdc.201500051.

PMID:
25788466
11.

Synthesis and evaluation of novel monosubstituted sulfonylurea derivatives as antituberculosis agents.

Pan L, Jiang Y, Liu Z, Liu XH, Liu Z, Wang G, Li ZM, Wang D.

Eur J Med Chem. 2012 Apr;50:18-26. doi: 10.1016/j.ejmech.2012.01.011.

PMID:
22326144
12.

Synthesis, biological evaluation and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis.

Castagnolo D, De Logu A, Radi M, Bechi B, Manetti F, Magnani M, Supino S, Meleddu R, Chisu L, Botta M.

Bioorg Med Chem. 2008 Sep 15;16(18):8587-91. doi: 10.1016/j.bmc.2008.08.016.

PMID:
18752962
13.

Synthesis and antitubercular activity of novel 3,5-diaryl-4,5-dihydro-1H-pyrazole derivatives.

Alegaon SG, Alagawadi KR, Dadwe DH.

Drug Res (Stuttg). 2014 Oct;64(10):553-8. doi: 10.1055/s-0033-1363976.

PMID:
24446205
14.

Synthesis and antitubercular activity of heteroaromatic isonicotinoyl and 7-chloro-4-quinolinyl hydrazone derivatives.

Ferreira Mde L, Gonçalves RS, Cardoso LN, Kaiser CR, Candea AL, Henriques Md, Lourenço MC, Bezerra FA, de Souza MV.

ScientificWorldJournal. 2010 Jul 7;10:1347-55. doi: 10.1100/tsw.2010.124.

15.

Synthesis, antitubercular and antimicrobial evaluation of 3-(4-chlorophenyl)-4-substituted pyrazole derivatives.

Pathak RB, Chovatia PT, Parekh HH.

Bioorg Med Chem Lett. 2012 Aug 1;22(15):5129-33. doi: 10.1016/j.bmcl.2012.05.063.

PMID:
22695129
17.

Pyrrolnitrin and related pyrroles endowed with antibacterial activities against Mycobacterium tuberculosis.

Di Santo R, Costi R, Artico M, Massa S, Lampis G, Deidda D, Pompei R.

Bioorg Med Chem Lett. 1998 Oct 20;8(20):2931-6.

PMID:
9873650
18.

Synthesis of glycosylated beta-amino acids as new class of antitubercular agents.

Tripathi RP, Tripathi R, Tiwari VK, Bala L, Sinha S, Srivastava A, Srivastava R, Srivastava BS.

Eur J Med Chem. 2002 Sep;37(9):773-81.

PMID:
12350294
19.

Synthesis of novel [1,2]-diamines with antituberculosis activity.

Meng Q, Luo H, Chen Y, Wang T, Yao Q.

Bioorg Med Chem Lett. 2009 Sep 15;19(18):5372-5. doi: 10.1016/j.bmcl.2009.07.126.

PMID:
19682895
20.

Synthesis of novel pleuromutilin derivatives. Part 1: preliminary studies of antituberculosis activity.

Dong YJ, Meng ZH, Mi YQ, Zhang C, Cui ZH, Wang P, Xu ZB.

Bioorg Med Chem Lett. 2015 Apr 15;25(8):1799-803. doi: 10.1016/j.bmcl.2015.02.023.

PMID:
25736994

Supplemental Content

Support Center